A carregar...
Trastuzumab: a novel standard option for patients with HER-2-positive advanced gastric or gastro-oesophageal junction cancer
The human epidermal receptor-2 (HER-2) is amplified in up to 25% of patients with gastroesophageal adenocarcinomas. Although the presence of this amplification does not appear to confer a poor prognosis, it provides a valuable novel therapeutic target for this group of patients. Trastuzumab is a ful...
Na minha lista:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2012
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3437538/ https://ncbi.nlm.nih.gov/pubmed/22973416 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756283X12450246 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|